CN Patent

CN114728905B — 治疗性化合物及使用方法

Assigned to Genentech Inc · Expires 2025-08-01 · 1y expired

What this patent protects

本发明涉及化合物和使用所述化合物的方法，以及含有此类化合物的药物组合物，其用于治疗由TEAD介导的疾病和病症，诸如癌症。

USPTO Abstract

本发明涉及化合物和使用所述化合物的方法，以及含有此类化合物的药物组合物，其用于治疗由TEAD介导的疾病和病症，诸如癌症。

Drugs covered by this patent

Patent Metadata

Patent number
CN114728905B
Jurisdiction
CN
Classification
—
Expires
2025-08-01
Drug substance claim
No
Drug product claim
No
Assignee
Genentech Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.